Biologic Tapering in axSpA: What Research Says and What it Means for Patients
Spondycast by The Spondylitis Association of America (SAA)
Episode notes
Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.
Keywords
researchmedicationflaresbiologic taperingTNF Inhibitors